These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9183562)

  • 1. Evaluation of the developmental toxicity of benzo[a]pyrene and 2-acetylaminofluorene using Xenopus: modes of biotransformation. Stover Group.
    Propst TL; Fort DJ; Stover EL; Schrock B; Bantle JA
    Drug Chem Toxicol; 1997; 20(1-2):45-61. PubMed ID: 9183562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification.
    Fort DJ; Stover EL; Bantle JA; Finch RA
    Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
    Fort DJ; Bantle JA
    Fundam Appl Toxicol; 1990 May; 14(4):720-33. PubMed ID: 2361573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the developmental toxicity of 4-bromobenzene using frog embryo teratogenesis assay--Xenopus: possible mechanisms of action.
    Fort DJ; Propst TL; Stover EL
    Teratog Carcinog Mutagen; 1996; 16(6):307-15. PubMed ID: 9178453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the developmental toxicities of coumarin, 4-hydroxycoumarin, and 7-hydroxycoumarin using FETAX.
    Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
    Drug Chem Toxicol; 1998 Feb; 21(1):15-26. PubMed ID: 9530527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acetaminophen-induced developmental toxicity using FETAX.
    Fort DJ; Rayburn JR; Bantle JA
    Drug Chem Toxicol; 1992; 15(4):329-50. PubMed ID: 1459044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus.
    Fort DJ; Stover EL; Propst T; Hull MA; Bantle JA
    Drug Chem Toxicol; 1996 Nov; 19(4):267-78. PubMed ID: 8972234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system.
    Fort DJ; James BL; Bantle JA
    J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures.
    Fort DJ; Rogers RL; Stover EL; Finch RA
    Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the developmental toxicity of trichloroethylene and detoxification metabolites using Xenopus.
    Fort DJ; Stover EL; Rayburn JR; Hull M; Bantle JA
    Teratog Carcinog Mutagen; 1993; 13(1):35-45. PubMed ID: 8100651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens.
    Perrone CE; Ahr HJ; Duan JD; Jeffrey AM; Schmidt U; Williams GM; Enzmann HH
    Arch Toxicol; 2004 Oct; 78(10):589-98. PubMed ID: 15167984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450.
    McManus ME; Burgess WM; Veronese ME; Huggett A; Quattrochi LC; Tukey RH
    Cancer Res; 1990 Jun; 50(11):3367-76. PubMed ID: 2334931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic interactions between low doses of benzo[a]pyrene and tributyltin in arctic charr (Salvelinus alpinus): a long-term in vivo study.
    Padrós J; Pelletier E; Ribeiro CO
    Toxicol Appl Pharmacol; 2003 Oct; 192(1):45-55. PubMed ID: 14554102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of benzo[a]pyrene on metabolic activation of anticancer drug ellipticine in mice.
    Stiborova M; Cerna V; Moserova M; Arlt VM; Frei E
    Neuro Endocrinol Lett; 2013; 34 Suppl 2():43-54. PubMed ID: 24362092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in immune function and CYP450 activity in adult male deer mice (Peromyscus maniculatus) following exposure to benzo[a]pyrene, pyrene, or chrysene.
    Peden-Adams MM; Liu J; Knutson S; Dancik J; Bryant K; Bodine AB; Dickerson RL
    J Toxicol Environ Health A; 2007 Nov; 70(21):1783-91. PubMed ID: 17934950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abundance of aryl hydrocarbon receptor potentiates benzo[a]pyrene-induced apoptosis in Hepa1c1c7 cells via CYP1A1 activation.
    Chung JY; Kim JY; Kim WR; Lee SG; Kim YJ; Park JE; Hong YP; Chun YJ; Park YC; Oh S; Yoo KS; Yoo YH; Kim JM
    Toxicology; 2007 Jun; 235(1-2):62-72. PubMed ID: 17433523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of chemotherapeutic drugs on the CYP1A1-catalysed metabolism of the environmental carcinogen benzo[a]pyrene: Effects in human colorectal HCT116 TP53(+/+), TP53(+/-) and TP53(-/-) cells.
    Willis AJ; Indra R; Wohak LE; Sozeri O; Feser K; Mrizova I; Phillips DH; Stiborova M; Arlt VM
    Toxicology; 2018 Apr; 398-399():1-12. PubMed ID: 29471073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cytochrome P-450 from hepatic nuclear membranes of rats fed 2-acetylaminofluorene.
    Carubelli R; Palakodety RB; Griffin MJ
    Chem Biol Interact; 1986 May; 58(2):125-36. PubMed ID: 3087637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.